Ophthalmology

Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.

A small study found that decreased retinal vascular density identified by optical coherence tomography angiography may be linked to faster visual field loss at extended follow-up.

Judith Lavrich, MD, and Jordan Hamburger discuss the need for more research on the impact of screen time on eye health following their study on virtual school and children's eyesight.

Expert perspectives on the factors that inform therapy selection when managing patients with glaucoma.

Experts debate the use of generic agents over branded therapy when managing patients with glaucoma.

SARS-CoV-2 might target lacrimal glands, causing eyelid swelling due to chronic dacryoadenitis after COVID-19 infection.

David Ramsey, MD, PhD, MPH, outlines why patients with diabetes should undergo regular eye examinations.

A broad review of therapeutic classes approved for the management of glaucoma and how they may be sequenced.

Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.

James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, lists potential solutions to bolster ophthalmic trauma care in the United States.

The treatment was approved in October 2021 and is the first FDA-approved therapy to treat macular edema associated with uveitis via injection to the suprachoroidal space, which provides a more targeted delivery mechanism.

Experts highlight early detection and the goals of therapy when managing patients with glaucoma.

A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.

A recent analysis found a strong negative correlation between plasma THC levels and intraocular pressure in healthy adults after smoking cannabis.

This represents the approval of the first bispecific antibody to treat wet age-related macular degeneration (AMD) and diabetic macular edema (DME).

A recent study suggests a conceptual deep neural network–based surgical guidance platform is precise and has potential as a valuable tool during phacoemulsification procedures.

One of the long-term effects of COVID-19 may be small fiber neuropathy in the ocular surface causing similar symptoms to dry eye disease and diabetic neuropathy, a recent study found.

Recent findings suggest that with more research, anomaly detection may be an option for general retinal disease screening and identification of novel presentations of common retinal diseases.

A large real-world analysis assessed age-related changes in commonly used visual field reliability indices and the potential mechanisms behind the trends.

One-year outcomes varied among patients with differing neovascular glaucoma etiologies, but many achieved meaningful vision after surgical treatment that included glaucoma drainage devices.

Results of a cross-sectional study highlight features linked with high myopia in Dutch individuals.

The top 5 most-read ophthalmology articles of 2021 on AJMC.com evaluated the effectiveness of novel therapies in several ophthalmic diseases, racial/ethnic disparities in clinical trial participation, and the impact of the COVID-19 pandemic on childhood nearsightedness.

In India, incidence of the deadly fungal infection grew throughout 2021, while supply chain shortages inhibited optimal treatment for each patient.

Results of a retrospective cohort study show youth with type 2 diabetes were almost twice as likely to develop retinopathy compared with those with type 1 diabetes.

Victoria Ly, MD, MPH, outlines one method of tackling vision screening follow-up rate disparities among children in Arkansas.